Do SGLT2 Inhibitors Improve Cardiovascular Outcomes After Acute Coronary Syndrome Regardless of Diabetes? A Systematic Review and Meta-Analysis.

Medicina (Kaunas) · 2025 · PMC12566139 · PMID 41155853

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although this did not reach statistical significance, and heterogeneity was moderate (I 2 = 67.6%), Figure 4 C.

also in 111,027 other papers

showed a trendno p-value reported

Stroke—Subgroup Analysis by Diabetes Status In patients with T2DM, pooled analysis showed a trend toward reduced risk of stroke associated with SGLT2 inhibitors, although not statistically significant.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.